In Case You Missed It Thursday: Everyone (but Pfizer) May Still Need Some Advil
Pfizer could sell the Advil franchise. After being created by Whitehall and released in 1984, Pfizer acquired the brand in 2009 through Wyeth Pharmaceuticals. Here's an ad from 1985.

If you'd like to receive "In Case You Missed It" in your email inbox every evening, please register for TheStreet Alerts and follow me.

Have you adjusted yet? Well, the markets are still figuring out the new world under President-elect Donald Trump, as Wall Street ran at two speeds on Thursday. A rally in financials sent the Dow Jones Industrial Average to close at records, while a selloff in tech sank the Nasdaq.

So while the markets, investors, dealmakers and hedge funds watched the indicies run off in either direction, TheStreet and its affiliates were watching key earnings from Disney ( DIS) , Macy's ( M) , Nvidia ( NVDA)  , SolarCity ( SCTY) and a host of other companies, as well as Pershing Square's investor day and OPEC's production cap that doesn't seem to actually be happening.

Pfizer (PFE) is reportedly looking to sell a swath of over-the-counter products, including its Advil and Chapstick franchises, that could net the company $14 billion, and there was a big dip in U.S. Treasuries that could present a buying opportunity for some.

But that wasn't all to report today as we all continued to adjust to the post-election markets. Here are the highlights from TheStreet and its affiliates:

MannKind is Still Too Heavy to Avoid the Afrezza Crash Landing
MannKind (MNKD) bulls—the rainbow-hued unicorns of the investment world—believe the company's marketing efforts will succeed. They're wrong. Full story

Strong Flash Memory Prices Are Good News for Some Firms, but a Mixed Blessing for Others
Booming demand for mobile storage and data center solid state drives is helping memory makers. Hard drive makers are benefiting indirectly for now, but they have reasons to be nervous. Full story

Tweet of the Day: 

Ackman: "Think about Valeant in a world in which it sold half or all its noncore assets, plus Salix" https://t.co/wZamSVF7ES" $VRX

— James Passeri (@JamesPasseri) November 10, 2016

Donald Trump's Victory May Be a Win for Wall Street Traders, Too
Trading revenues at the biggest U.S. banks surged after Britain's decision to leave the European Union. More of the same is possible now, for companies from JPMorgan (JPM) to Goldman Sachs (GS) . Full story

Could Theranos be next to file for bankruptcy?
The embattled biotech company faces yet another lawsuit, this time from AAP holding Walgreens Boots Alliance (WBA) . Full story 

Chart of the Day: Colgate-Palmolive (CL) Remains on Slippery Slope for Now

 

In the short run the stock is likely to stay on the defensive and test the $68 to $67 area. Full story

Twitter (TWTR) COO's Departure Doesn't Suggest a Turnaround or Sale Is Near
Just weeks after reportedly seeing potential suitors walk away, the struggling social media company names a new second-in-command. Full story

Vidoe of the Day: Guggenheim's Scott Minerd Pushed by Democrats for Treasury Secretary - Source


Democratic leadership hasn't abandoned pushing for Scott Minerd of Guggenheim Partners to become Secretary of the Treasury, according to a person familiar with the matter. Full story

More from Stocks

Investors Face Growing Opportunities and Challenges in Cannabis

Investors Face Growing Opportunities and Challenges in Cannabis

J.C. Penney Shares Have Plunged 64% Since Quant Ratings Downgrade

J.C. Penney Shares Have Plunged 64% Since Quant Ratings Downgrade

The 'Fear of Missing Out' Is Missing

The 'Fear of Missing Out' Is Missing

Bye, Bye, Bye Sears: The Week Ahead

Bye, Bye, Bye Sears: The Week Ahead

Stocks Slip on Saudi Tensions, Trade Woes; Sears Goes Bankrupt

Stocks Slip on Saudi Tensions, Trade Woes; Sears Goes Bankrupt